Catalyst Wire Dossier Catalyst Wire Dossier

VRX-RET investigational epilepsy drug

· GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VRX-RET investigational epilepsy drug, covering 2012-10-29 to 2012-10-29. Get the full timeline:

Most recent: Clinical Trial Update: Meta-Analysis Plan for Pooled Data for Studies VRX-RET-E22-303 and VRX-RET-E22-304

See pricing